(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 3-[[2′-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate (as per EP) ; 1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2'-(2-ethyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl}methyl)-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate; Candesartan Cilexetil USP Related Compound D ; Candesartan Cilexetil N2-Ethyl Amide ; Candesartan Cilexetil O-Desethyl N2-Ethyl Analog ; 2-Desethoxy-2-Hydroxy-2H-N2-Ethyl Candesartan Cilexetil
Candesartan Cilexetil EP Impurity Dis a fully characterized chemical compound used as a reference standard of API Candesartan. The standard offered is compliant with regulatory guidelines.Candesartan Cilexetil EP Impurity Dis used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1185256-03-4
